Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian R Lane

Showing results (231-240 of 257) with videos related to

Pageof 26
Sort By:
Prostate Cancer and Prostatic Diseases|August 29, 2019
Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillanceAnnika Herlemann, Huei-Chung Huang, Ridwan Alam, et al.
Clinical Genitourinary Cancer|February 28, 2019
Neoadjuvant Sunitinib Decreases Inferior Vena Caval Thrombus Size and Is Associated With Improved Oncologic Outcomes: A Multicenter Comparative AnalysisCharles A Field, Brittney H Cotta, Juan Jimenez, et al.
Cancer|July 20, 2016
Randomized trial finds that prostate cancer genetic risk score feedback targets prostate-specific antigen screening among at-risk menAubrey R Turner, Brian R Lane, Dan Rogers, et al.
JAMA Oncology|November 22, 2019
Eligibility and Radiologic Assessment for Adjuvant Clinical Trials in Kidney CancerSundeep Agrawal, Naomi B Haas, Mohammadhadi Bagheri, et al.
Clinical Genitourinary Cancer|July 1, 2020
Oncologic and Functional Outcomes of Radical and Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: A Multi-institutional AnalysisSunil H Patel, Robert G Uzzo, Alessandro Larcher, et al.
Urologic Oncology|October 25, 2023
Development of a novel score (RENSAFE) to determine probability of acute kidney injury and renal functional decline post surgery: A multicenter analysisCesare Saitta, Jonathan A Afari, Riccardo Autorino, et al.
Prostate Cancer and Prostatic Diseases|December 14, 2018
Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillanceHyung L Kim, Ping Li, Huei-Chung Huang, et al.
The Journal of Urology|October 15, 2019
Impact of Resection Technique on Perioperative Outcomes and Surgical Margins after Partial Nephrectomy for Localized Renal Masses: A Prospective Multicenter StudyAndrea Minervini, Riccardo Campi, Brian R Lane, et al.
Cancer|April 20, 2017
Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO-IMPACT studyJohn L Gore, Marguerite du Plessis, María Santiago-Jiménez, et al.
European Urology|October 8, 2024
Impact of Gene Expression Classifier Testing on Adjuvant Treatment Following Radical Prostatectomy: The G-MINOR Prospective Randomized Cluster-crossover TrialTodd M Morgan, Stephanie Daignault-Newton, Daniel E Spratt, et al.
Pageof 26

Showing results (231-240 of 257) with videos related to

Sort By:
Pageof 26
Prostate Cancer and Prostatic Diseases|August 29, 2019
Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillanceAnnika Herlemann, Huei-Chung Huang, Ridwan Alam, et al.
Clinical Genitourinary Cancer|February 28, 2019
Neoadjuvant Sunitinib Decreases Inferior Vena Caval Thrombus Size and Is Associated With Improved Oncologic Outcomes: A Multicenter Comparative AnalysisCharles A Field, Brittney H Cotta, Juan Jimenez, et al.
Cancer|July 20, 2016
Randomized trial finds that prostate cancer genetic risk score feedback targets prostate-specific antigen screening among at-risk menAubrey R Turner, Brian R Lane, Dan Rogers, et al.
JAMA Oncology|November 22, 2019
Eligibility and Radiologic Assessment for Adjuvant Clinical Trials in Kidney CancerSundeep Agrawal, Naomi B Haas, Mohammadhadi Bagheri, et al.
Clinical Genitourinary Cancer|July 1, 2020
Oncologic and Functional Outcomes of Radical and Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: A Multi-institutional AnalysisSunil H Patel, Robert G Uzzo, Alessandro Larcher, et al.
Urologic Oncology|October 25, 2023
Development of a novel score (RENSAFE) to determine probability of acute kidney injury and renal functional decline post surgery: A multicenter analysisCesare Saitta, Jonathan A Afari, Riccardo Autorino, et al.
Prostate Cancer and Prostatic Diseases|December 14, 2018
Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillanceHyung L Kim, Ping Li, Huei-Chung Huang, et al.
The Journal of Urology|October 15, 2019
Impact of Resection Technique on Perioperative Outcomes and Surgical Margins after Partial Nephrectomy for Localized Renal Masses: A Prospective Multicenter StudyAndrea Minervini, Riccardo Campi, Brian R Lane, et al.
Cancer|April 20, 2017
Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO-IMPACT studyJohn L Gore, Marguerite du Plessis, María Santiago-Jiménez, et al.
European Urology|October 8, 2024
Impact of Gene Expression Classifier Testing on Adjuvant Treatment Following Radical Prostatectomy: The G-MINOR Prospective Randomized Cluster-crossover TrialTodd M Morgan, Stephanie Daignault-Newton, Daniel E Spratt, et al.
Pageof 26